RICHARD KETCHAM: Open Payments
NPI 1639714819 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136 in 7 payments from 6 companies in 2025. Trend: 2023 $425 · 2024 $75 · 2025 $136
Food & beverage: $136
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $34 |
| Janssen Biotech, Inc. | 2 | $32 |
| ORPHALAN INC | 1 | $25 |
| Celltrion USA Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: REZDIFFRA, TREMFYA, CUVRIOR, VEGZELMA, RINVOQ, OMVOH.
Industry payments across AL — which companies pay providers there.
